The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| AGEX THERAPEUTICS INC | COM | 00848H108 | 5,874 | 2,997,156 | SH | DFND | 1 | 2,997,156 | 0 | 0 | |
| AXON ENTERPRISE INC | COM | 05464C101 | 43,156 | 760,062 | SH | DFND | 1 | 760,062 | 0 | 0 | |
| ISHARES TR | RUSSELL 2000 ETF | 464287655 | 63,563 | 420,000 | SH | DFND | 1 | 420,000 | 0 | 0 | |
| LINEAGE CELL THERAPEUTICS IN | COM | 53566P109 | 33,325 | 34,005,379 | SH | DFND | 1 | 34,005,379 | 0 | 0 | |
| MONSTER BEVERAGE CORP NEW | COM | 61174X109 | 271,681 | 4,679,308 | SH | DFND | 1 | 4,679,308 | 0 | 0 | |
| ONCOCYTE CORPORATION | COM | 68235C107 | 23,306 | 11,098,267 | SH | DFND | 1 | 11,098,267 | 0 | 0 | |
| STAAR SURGICAL CO | COM PAR $0.01 | 852312305 | 279,471 | 10,840,630 | SH | DFND | 1 | 10,840,630 | 0 | 0 | |